Over the years, CRYOPDP teams have collaborated closely with our clients and partners, creating tailor-made and innovative solutions for their investigational sites’ supply-chain needs.
In response to increasing demand, we’re expanding our expertise to encompass direct-to-patient supply solutions, demonstrating our commitment to delivering tailored service excellence in the direct-to-patient arena.
CRYOPDP specialised teams are dedicated to developing custom Direct-to-Patient (DtP) tailor-made projects based on the most demanding customer-specific requirements.
- Country Selection: Each country has unique regulations. We ensure compliance by tailoring processes to meet specific standards.
- Drug Type: Different drugs have varying requirements. We ensure safe transportation by meeting specific temperature and control needs.
- Security: Rigorous risk assessment ensures adherence to global regulations, maintaining product integrity across the supply chain.
- Supply Chain Partners’ Capabilities: Collaborating with closely monitored partners guarantees reliable and punctual deliveries, ensuring a seamless end-to-end supply chain.
- Communication: Maintaining regular, effective communication channels is vital. Addressing patient needs promptly ensures an efficient process.
- Good Clinical Practices: Strict adherence to clinical instructions ensures compliance, confidentiality, and ethical practices.
- Good Distribution Practices: Prioritising GDP compliance minimises procedural and delivery risks, ensuring the safety and integrity of the entire distribution process.
- The Process: We understand the demands of DtP shipments. Collaborating closely with customers, we ensure meticulous control and security of sensitive patient data.